Causes of Mortality in Kidney Transplant Recipients

Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Sep 1, 2022

Keywords

ClinConnect Summary

This clinical trial is focused on understanding the reasons why kidney transplant patients may die and what factors might increase their risk. Recent research suggests that instead of mainly dying from heart-related issues, more patients are now facing deaths from infections and cancer. To explore this change, researchers are looking at information from two large databases in France that track kidney transplants. This study aims to identify these new trends and the related risk factors.

To participate in this trial, you need to be an adult (18 years or older) who received a kidney transplant between January 1, 2008, and December 31, 2014. You can also be part of the study if you had a combined transplant involving the kidney and pancreas or islets of Langerhans (which are cells in the pancreas). Participants will be asked to allow the use of their medical data for this research, but if you prefer not to be part of the study, that’s perfectly fine. If you join, the research team will analyze your data to help improve our understanding of kidney transplant outcomes over time.

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • Adult subject (≥18 years old) during transplantation
• • Transplantation performed between 01/01/2008 and 31/12/2014
• • Kidney transplant subject, double transplants kidney + pancreas, or kidney + islets of Langherans
• • Subject previously transplanted other organs
• • Subject not objecting, after being informed, to the reuse of their data for the purposes of this research
• Exclusion criteria:
• • Subject who expressed their opposition to participating in the study
• • Subject having received a double transplant during the same operation: kidney + heart, kidney + liver, kidney + lungs